Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult patient (age \>/= 18 years)
Presenting with WHO grade 1-3, CD20-positive follicular non-Hodgkin's lymphoma, histologically confirmed at initial diagnosis
In relapse (or refractory) after at least one line of treatment, regardless of the nature of previous treatments (chemotherapy and/or immunotherapy and/or radioimmunoconjugate therapy and/or radiation+chemotherapy) and for whom a decision was made to give salvage therapy
Having received oral and written information about the study and having raised no objections to electronic capture and processing of his/her personal data
You may not be if
Patient participating in a clinical trial evaluating a new, non-commercialized cancer treatment at the time of inclusion
Follicular lymphoma presenting with a transformation to diffuse large cell non-Hodgkin's lymphoma
First line treatment with radiotherapy alone
Initial abstention from treatment (decision to not treat the progression at the time of inclusion in the OLYMPE study)
